NBTX
NASDAQ HEALTHCARENanobiotix
$33.31
-$0.15 (-0.45%)
Live quote
52w: $14.78 – $57.14
Loading chart…
P/E Ratio—
P/B Ratio—
EV/EBITDA—
Debt/Equity—
ROE—
ROIC—
Revenue Growth—
Gross Margin—
Nanobiotix SA, a clinical-stage biotechnology, is focused on the development of candidate products for the treatment of cancer. The company is headquartered in Paris, France.
Own NBTX? Track it here.
Create a free account to add NBTX to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.